140 related articles for article (PubMed ID: 36066118)
21. Perineal Clear Cell Hidradenoma: A GATA3-positive Neoplasm With Potential for Misdiagnosis.
Hudacko R; Anderson P; Guerrieri C
Int J Gynecol Pathol; 2021 Sep; 40(5):465-469. PubMed ID: 32925441
[TBL] [Abstract][Full Text] [Related]
22. Tender finger nodule.
Klapperich ME; Buhalog BA; Hinshaw MA
Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906012
[TBL] [Abstract][Full Text] [Related]
23. Case Report and Literature Review of Nodular Hiradenoma, a Rare Adnexal Tumor That Mimics Breast Carcinoma, in a 20-Year-Old Woman.
Jaitly V; Jahan-Tigh R; Belousova T; Zhu H; Brown R; Saluja K
Lab Med; 2019 Jul; 50(3):320-325. PubMed ID: 30722042
[TBL] [Abstract][Full Text] [Related]
24. Update on Malignant Sweat Gland Tumors.
van der Horst MPJ; Brenn T
Surg Pathol Clin; 2017 Jun; 10(2):383-397. PubMed ID: 28477887
[TBL] [Abstract][Full Text] [Related]
25. Poroid hidradenoma in a child: an unusual presentation.
López V; Santonja N; Calduch-Rodríguez L; Jordá E
Pediatr Dermatol; 2011; 28(1):60-1. PubMed ID: 21276058
[TBL] [Abstract][Full Text] [Related]
26. Metastatic aggressive digital papillary adenocarcinoma.
Altman CE; Hamill RL; Elston DM
Cutis; 2003 Aug; 72(2):145-7. PubMed ID: 12953940
[TBL] [Abstract][Full Text] [Related]
27. Clear cell hidradenoma of the breast: a case report with review of the literature.
Ohi Y; Umekita Y; Rai Y; Kukita T; Sagara Y; Sagara Y; Takahama T; Andou M; Sagara Y; Yoshida A; Yoshida H
Breast Cancer; 2007; 14(3):307-11. PubMed ID: 17690510
[TBL] [Abstract][Full Text] [Related]
28. An aggressive treatment for aggressive digital papillary adenocarcinoma.
Inaloz HS; Patel GK; Knight AG
Cutis; 2002 Mar; 69(3):179-82; quiz 210. PubMed ID: 11926336
[TBL] [Abstract][Full Text] [Related]
29. Fine-needle aspiration cytology of apocrine hidradenoma.
Novak NP; Kaić G; Tomasović-Loncarić C; Zic R; Skoro M; Ostović KT
Coll Antropol; 2010 Jun; 34(2):671-4. PubMed ID: 20698151
[TBL] [Abstract][Full Text] [Related]
30. Papillary hidradenoma: immunohistochemical analysis of steroid receptor profile with a focus on apocrine differentiation.
Offidani A; Campanati A
J Clin Pathol; 1999 Nov; 52(11):829-32. PubMed ID: 10690173
[TBL] [Abstract][Full Text] [Related]
31. Mucinous syringometaplasia mimicked by a clear cell hidradenoma with mucinous change.
Hunt SJ; Abell E
J Cutan Pathol; 1991 Oct; 18(5):339-43. PubMed ID: 1662242
[TBL] [Abstract][Full Text] [Related]
32. Aggressive digital papillary adenocarcinoma (aggressive digital papillary adenoma and adenocarcinoma revisited).
Duke WH; Sherrod TT; Lupton GP
Am J Surg Pathol; 2000 Jun; 24(6):775-84. PubMed ID: 10843279
[TBL] [Abstract][Full Text] [Related]
33. Poroid hidradenoma: a light microscopic and immunohistochemical study.
Requena L; Sánchez M
Cutis; 1992 Jul; 50(1):43-6. PubMed ID: 1325337
[TBL] [Abstract][Full Text] [Related]
34. Aggressive digital papillary adenoma and adenocarcinoma. A clinicopathological study of 57 patients, with histochemical, immunopathological, and ultrastructural observations.
Kao GF; Helwig EB; Graham JH
J Cutan Pathol; 1987 Jun; 14(3):129-46. PubMed ID: 3301927
[TBL] [Abstract][Full Text] [Related]
35. Cytologic features of hidradenoma in fine needle aspiration biopsies.
Dubb M; Michelow P
Acta Cytol; 2009; 53(2):179-82. PubMed ID: 19365971
[TBL] [Abstract][Full Text] [Related]
36. Coexpression of S-100 and smooth muscle actin in nodular hidradenoma.
Vodovnik A
Am J Dermatopathol; 2003 Aug; 25(4):361-2. PubMed ID: 12876503
[No Abstract] [Full Text] [Related]
37. Papillary tubular adenoma with marked tubular vacuolization.
Hattori N; Imakado S; Kikuchi K; Murakami T; Furue M
J Dermatol; 1997 Dec; 24(12):777-80. PubMed ID: 9492442
[TBL] [Abstract][Full Text] [Related]
38. Syringadenocarcinoma papilliferum.
Numata M; Hosoe S; Itoh N; Munakata Y; Hayashi S; Maruyama Y
J Cutan Pathol; 1985 Feb; 12(1):3-7. PubMed ID: 2982933
[TBL] [Abstract][Full Text] [Related]
39. Perineural growth of benign cutaneous sweat gland tumors: a hitherto unrecognized phenomenon unassociated with malignancy.
Luzar B; Shanesmith R; Calonje E
J Cutan Pathol; 2015 Nov; 42(11):878-83. PubMed ID: 26260952
[TBL] [Abstract][Full Text] [Related]
40. Limited immunoexpression of fibroblast growth factor receptor 2 (FGFR2) in digital papillary adenocarcinoma: Comparison of FGFR2 immunohistochemistry between digital papillary adenocarcinoma, other sweat gland tumors and normal skin tissue.
Satake K; Goto K; Sugino T; Sasaki Y; Yoshikawa S; Kiyohara Y
J Dermatol; 2021 Feb; 48(2):e86-e87. PubMed ID: 33210330
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
